home.social

#therapeutics — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #therapeutics, aggregated by home.social.

  1. European Commission grants marketing authorization for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral adrenoleukodystrophy (cALD), a rare neurodegenerative disease

    Neuraxpharm Group and Minoryx Therapeutics, today announce that the European Commission (EC) has granted marketing authorization unde…
    #Europe #EU #Adrenoleukodystrophy #Agonist #brain #European #Gadolinium #NeurodegenerativeDisease #therapeutics #therapy
    europesays.com/europe/146770/